Effect of Compound 21-A Selective Angiotensin II Type 2 Receptor Agonist in an Abdominal Adhesion Murine Model

被引：0
|
作者：
Boudreau, C. G. [1 ]
Levatte, T. [1 ]
Gareau, A. [2 ]
Legere, S. [1 ]
Bezuhly, M. [3 ]
机构：
[1] Dalhousie Univ, Med, Halifax, NS, Canada
[2] Calgary Lab Serv, Calgary, AB, Canada
[3] Dalhousie Univ, Dept Plast Surg, Halifax, NS, Canada
来源：
ANNALS OF SURGICAL ONCOLOGY | 2020年 / 27卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P317
引用
收藏
页码：S171 / S171
页数：1
相关论文
共 50 条
  • [21] Role of interleukin-10 in the neuroprotective effect of the Angiotensin Type 2 Receptor agonist, compound 21, after ischemia/reperfusion injury
    Fouda, Abdelrahman Y.
    Pillai, Bindu
    Dhandapani, Krishnan M.
    Ergul, Adviye
    Fagan, Susan C.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 799 : 128 - 134
  • [22] Administration of Direct Angiotensin II Type-2 Receptor Agonist, Compound 21, Even After Stroke Prevents Ischemic Brain Damage
    Mogi, Masaki
    Min, Li-Juan
    Jing, Fei
    Tsukuda, Kana
    Ohshima, Kousei
    Nakaoka, Hirotomo
    Iwanami, Jun
    Horiuchi, Masatsugu
    STROKE, 2013, 44 (02)
  • [23] Central Infusion of Angiotensin II Type 2 Receptor Agonist Compound 21 Attenuates DOCA/NaCl-Induced Hypertension in Female Rats
    Dai, Shu-Yan
    Zhang, Yu-Ping
    Peng, Wei
    Shen, Ying
    He, Jing-Jing
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2016, 2016
  • [24] Comparison of the effects of losartan, captopril, angiotensin II type 2 receptor agonist compound 21, and MAS receptor agonist AVE 0991 on myocardial ischemia-reperfusion necrosis in rats
    Djerada, Zoubir
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 (04) : 667 - 668
  • [25] Prevention of diabetic nephropathy by compound 21, selective agonist of angiotensin type 2 receptors, in Zucker diabetic fatty rats
    Castoldi, Giovanna
    di Gioia, Cira R. T.
    Bombardi, Camila
    Maestroni, Silvia
    Carletti, Raffaella
    Steckelings, U. Muscha
    Dahloef, Bjorn
    Unger, Thomas
    Zerbini, Gianpaolo
    Stella, Andrea
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2014, 307 (10) : F1123 - F1131
  • [26] Enhancement of Cerebrovascular Relaxation by Angiotensin II Type 2 Receptor Agonist, C21, is Lost in Type 2 Diabetes
    Fouda, Abdelrahman Y.
    Hardigan, Trevor
    Soliman, Sahar
    Pillai, Bindu
    Ergul, Adviye
    Fagan, Susan
    HYPERTENSION, 2014, 64
  • [27] The Tumor Suppressive Effect of Angiotensin II Type 1 Receptor Antagonist in a Murine Osteosarcoma Model
    Wasa, Junji
    Sugiura, Hideshi
    Kozawa, Eiji
    Kohyama, Keishi
    Yamada, Kenji
    Taguchi, Osamu
    ANTICANCER RESEARCH, 2011, 31 (01) : 123 - 127
  • [28] A potential new therapy for pulmonary hypertension with the use of compound 21, an angiotensin type 2 receptor (AT2R) agonist
    Bruce, Erin
    Shenoy, Vinayak
    Rathinasabapathy, Anandharajan
    Steckelings, U. Muscha
    Unger, Thomas
    Sumners, Colin
    Raizada, Mohan K.
    Katovich, Michael J.
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [29] The effect of angiotensin II type 2 receptor agonist treatment on doxorubicin induced heart failure
    Ermis, N.
    Ozhan, O.
    Ulutas, Z.
    Vardi, N.
    Colak, C.
    Parlakpinar, H.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1318 - 1318
  • [30] The angiotensin type 2 receptor agonist Compound 21 elicits cerebroprotection in endothelin-1 induced ischemic stroke
    Joseph, Jason P.
    Mecca, Adam P.
    Regenhardt, Robert W.
    Bennion, Douglas M.
    Rodriguez, Vermali
    Desland, Fiona
    Patel, Neal A.
    Pioquinto, David J.
    Unger, Thomas
    Katovich, Michael J.
    Steckelings, U. Muscha
    Sumners, Colin
    NEUROPHARMACOLOGY, 2014, 81 : 134 - 141
12345